Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

Copy For Citation

Kilickap S., Demirci U., Bugdayci F., Tural D., Korkmaz T., Paydas S., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.14, no.10, 2019 (SCI-Expanded)

• Publication Type: Article / Abstract
• Volume: 14 Issue: 10
• Publication Date: 2019
• Doi Number: 10.1016/j.jtho.2019.08.1166
• Journal Name: JOURNAL OF THORACIC ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Hacettepe University Affiliated: Yes